The Prevalence and Spectrum of Alpha and Beta Thalassaemia in Guangdong Province: Implications for the Future Health Burden and Population Screening

Overview

Journal J Clin Pathol

Specialty Pathology

Date 2004 Apr 29

PMID 15113860

Citations 102

Authors

X M Xu

Y Q Zhou

G X Luo

C Liao

M Zhou

P Y Chen

J P Lu

S Q Jia

G F Xiao

X Shen

J Li

H P Chen

Y Y Xia

Y X Wen

Q H Mo

W D Li

Y Y Li

L W Zhuo

Z Q Wang

Y J Chen

C H Qin

M Zhong

Affiliations

Soon will be listed here.

Abstract

Aim: Thalassaemia is a good candidate disease for control by preventive genetic programmes in developing countries. Accurate population frequency data are needed for planning the control of thalassaemia in the high risk Guangdong Province of southern China.

Methods: In total, 13397 consecutive samples from five geographical areas of Guangdong Province were analysed for both haematological and molecular parameters.

Results: There was a high prevalence of carriers of alpha thalassaemia (8.53%), beta thalassaemia (2.54%), and both alpha and beta thalassaemia (0.26%). Overall, 11.07% of the population in this area were heterozygous carriers of alpha and beta thalassaemia. The mutation spectrum of alpha and beta thalassaemia and its constitution were fully described in this area. This study reports the true prevalence of silent alpha thalassaemia in the southern China population for the first time. In addition, two novel mutations that give rise to alpha thalassaemia, one deletion resulting in beta thalassaemia, and a rare deletion (--(THAI) allele) previously unreported in mainland China were detected. The frequency of the most common mutation, the Southeast Asian type of deletion (--(SEA), accounting for 48.54% of all alpha thalassaemias) was similar to the total of two alpha(+) thalassaemia deletions (-alpha(3.7) and -alpha(4.2), accounting for 47.49% of alpha thalassaemia).

Conclusion: Both alpha and beta thalassaemia are widely distributed in Guangdong Province of China. The knowledge gained in this study will enable the projected number of pregnancies at risk to be estimated and a screening strategy for control of thalassaemia to be designed in this area.

Citing Articles

Application of third-generation sequencing technology in the genetic testing of thalassemia.

Li W, Ye Y Mol Cytogenet. 2024; 17(1):32.

PMID: 39696632 PMC: 11657128. DOI: 10.1186/s13039-024-00701-4.

A particular focus on the prevalence of α-thalassemia and β-thalassemia among pregnant women in Changsha County, Hunan Province.

Xia Y, Huang C, Yang M, Zhang M, Lu Y Front Genet. 2024; 15:1422462.

PMID: 39574796 PMC: 11578977. DOI: 10.3389/fgene.2024.1422462.

Application of third-generation sequencing technology for identifying rare α- and β-globin gene variants in a Southeast Chinese region.

Zhuang J, Wang J, Huang N, Zheng Y, Xu L BMC Med Genomics. 2024; 17(1):241.

PMID: 39354459 PMC: 11445875. DOI: 10.1186/s12920-024-02014-2.

Evaluation of the immunization efficacy and adverse reactions of hepatitis B vaccination in children with thalassemia minor.

Han X, Zhang X, Zhong L, Liu Y, Gong L, Zhang J BMC Public Health. 2024; 24(1):2641.

PMID: 39334137 PMC: 11438186. DOI: 10.1186/s12889-024-18779-1.

Case report: A rare heterozygous Hb CS with heterozygous HbE in a family with thalassemia in China.

Wang D, Zhang H, Yang Z, Su W, Dou Y, Xu Y Heliyon. 2024; 10(18):e37858.

PMID: 39323799 PMC: 11422044. DOI: 10.1016/j.heliyon.2024.e37858.

References

Liu Y, Old J, Miles K, Fisher C, Weatherall D, Clegg J . Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000; 108(2):295-9. DOI: 10.1046/j.1365-2141.2000.01870.x. View

Ko T, Chen T, Hsieh M, Tseng L, Hsieh F, Chuang S . Alpha-thalassemia in the four major aboriginal groups in Taiwan. Hum Genet. 1993; 92(1):79-80. DOI: 10.1007/BF00216149. View

Liang R, Liang S, Jiang N, Wen X, Zhao J, Nechtman J . Alpha and beta thalassaemia among Chinese children in Guangxi Province, P.R. China: molecular and haematological characterization. Br J Haematol. 1994; 86(2):351-4. DOI: 10.1111/j.1365-2141.1994.tb04738.x. View

Waye J, Eng B, Cai S, Patterson M, Smith J, Tang W . Carrier detection and prenatal diagnosis of hemoglobinopathies in Ontario. Clin Invest Med. 1993; 16(5):358-71. View

Zeng Y, Huang S . Disorders of haemoglobin in China. J Med Genet. 1987; 24(10):578-83. PMC: 1050282. DOI: 10.1136/jmg.24.10.578. View

Fischel-Ghodsian N, Vickers M, SEIP M, Winichagoon P, Higgs D . Characterization of two deletions that remove the entire human zeta-alpha globin gene complex (- -THAI and - -FIL). Br J Haematol. 1988; 70(2):233-8. DOI: 10.1111/j.1365-2141.1988.tb02469.x. View

Chen F, Ooi C, Ha S, Cheung B, Todd D, Liang R . Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med. 2000; 343(8):544-50. DOI: 10.1056/NEJM200008243430804. View

Weatherall D . Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001; 2(4):245-55. DOI: 10.1038/35066048. View

Xu X, Liao C, Liu Z, Huang Y, Zhang J, Li J . Antenatal screening and fetal diagnosis of beta-thalassemia in a Chinese population: prevalence of the beta-thalassemia trait in the Guangzhou area of China. Hum Genet. 1996; 98(2):199-202. DOI: 10.1007/s004390050190. View

10.

Zeng Y, Huang S . Alpha-globin gene organisation and prenatal diagnosis of alpha-thalassaemia in Chinese. Lancet. 1985; 1(8424):304-7. DOI: 10.1016/s0140-6736(85)91081-5. View

11.

Chui D, Fucharoen S, Chan V . Hemoglobin H disease: not necessarily a benign disorder. Blood. 2002; 101(3):791-800. DOI: 10.1182/blood-2002-07-1975. View

12.

Penchaszadeh V, Christianson A, Giugliani R, Boulyjenkov V, Katz M . Services for the prevention and management of genetic disorders and birth defects in developing countries. Community Genet. 2004; 2(4):196-201. DOI: 10.1159/000016212. View

13.

Chan L, Ma S, Chan A, Ha S, Waye J, Lau Y . Should we screen for globin gene mutations in blood samples with mean corpuscular volume (MCV) greater than 80 fL in areas with a high prevalence of thalassaemia?. J Clin Pathol. 2001; 54(4):317-20. PMC: 1731396. DOI: 10.1136/jcp.54.4.317. View

14.

Cao A, Rosatelli M, Monni G, Galanello R . Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am. 2002; 29(2):305-28, vi-vii. DOI: 10.1016/s0889-8545(01)00006-7. View

15.

Zhao Y, Zhong M, Liu Z, Xu X . [Rapid detection of the common alpha-thalassemia-2 determinants by PCR assay]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001; 18(3):216-8. View

16.

Wang S, Wang L, Zhang B, Wu G, Huang Y, Wang R . A survey of Hb Bart in cord blood and the alpha-globin gene in South China. Birth Defects Orig Artic Ser. 1987; 23(5A):23-30. View

17.

Fucharoen S, Winichagoon P, Wisedpanichkij R, Sriphanich R, Oncoung W, Muangsapaya W . Prenatal and postnatal diagnoses of thalassemias and hemoglobinopathies by HPLC. Clin Chem. 1998; 44(4):740-8. View

18.

Kyriacou K, Kyrri A, Kalogirou E, Vasiliades P, Angastiniotis M, Ioannou P . Hb Bart's levels in cord blood and alpha-thalassemia mutations in Cyprus. Hemoglobin. 2000; 24(3):171-80. DOI: 10.3109/03630260008997525. View

19.

Lam Y, Tang M . Risk of neural tube defects in the offspring of thalassaemia carriers in Hong Kong Chinese. Prenat Diagn. 1999; 19(12):1135-7. View

20.

Zhao J, Zhao L, Gu Y, HUISMAN T . Types of alpha-globin gene deficiencies in Chinese newborn babies in the Guangxi region, P. R. China. Hemoglobin. 1992; 16(4):325-8. DOI: 10.3109/03630269208998877. View